Stock Events

Stock Events

Spyre Therapeutics (3920.F) Q4 2023 Earnings

29FebConfirmed

Q4 2023

-3.75

-2.72

-1.7

-0.67

Details

Expected EPS

-0.67295101112

Actual EPS

-3.7478295

Surprise EPS

-3.07

Surprise Percent

+456.92%

Description

Spyre Therapeutics (3920.F) has reported earnings of -3.7478295 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.